The Robert J. Margolis, M.D., Center for Health Policy was established in January 2016 with a $16.5 million gift from Duke medical school alumnus Robert J. Margolis and his wife Lisa, through the Robert and Lisa Margolis Family Foundation.
Duke-Margolis brings together capabilities that generate and analyze evidence across the spectrum of policy to practice, supporting the triple aim of health care – improving the experience of care, the health of populations and reducing the per capita cost. This requires broad multidisciplinary capabilities that few institutions can bring together, and is fueled by Duke University’s entrepreneurial culture.
The Center integrates the expertise of Duke University scholars and academic health system with an established team experienced in convening stakeholders and conducting policy analysis. The Center is a catalyst, linking Duke’s world-class research and health care with policymakers and policy analysts in the public and private sector at the local, national and global levels. Disciplines involved in the Center include business, biomedical research, clinical care, public policy, population health, global health, law, the social sciences, and the humanities.
The Center is based at the Fuqua School of Business, with staff and offices in both Durham and at Duke’s center in Washington, D.C., and collaborates with experts on health care policy and practice from across the country and around the world.
Executive Leadership Team
Director and Robert J. Margolis, M.D., Professor of Business, Medicine and Health Policy
Mark B. McClellan, M.D., Ph.D., directs the Duke-Margolis Center, building on a distinguished career in academia and government focusing on health outcomes research, payment reforms, evidence-based policy methods, and drug and device innovation. In addition, he leads the Center’s health care delivery reform portfolio, which includes policy and data strategies for payment reform, accountable care organizations,
Deputy Director and Clinical Professor, Fuqua School of Business
Gregory W. Daniel, Ph.D., M.P.H., R.Ph., directs the Duke-Margolis office in Washington, D.C. He leads the Center's pharmaceutical and medical device policy portfolio, which includes policy and data strategies for improving development and access to innovative pharmaceutical and medical device technologies. His expertise spans post-market evidence development to support increased value, improving regulatory science and drug development tools, optimizing biomedical innovation, and supporting drug and device payment reform.
Chief Operating Officer
Victoria Christian directs the Center’s operations and strategic alignment. She has held executive leadership roles in clinical and translational research for pharmaceutical, biotechnology, CRO, and academic organizations.
Director of Communications
Ellen de Graffenreid, M.A., M.B.A., directs the center’s strategic communications, marketing and media relations. For more than fifteen years, she has led marketing and communications for organizations in higher education and academic medicine, leading cross-functional teams and serving as spokesperson and chief communications officer.